THE USE OF ADJUVANT ONCOLYTIC ADAPTED ECHO-7 VIRUS IMMUNOTHERAPY IN PRIMARY MALIGNANT MELANOMA OF CERVIX: CASE REPORT

2016 ◽  
Author(s):  
Elizabete Pumpure
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Primary Malignant Melanoma

scholarly journals Primary malignant melanoma of the trachea: A case report

2014 ◽  
Vol 9 (2) ◽  
pp. 657-660 ◽  
Author(s):  
HISAO IMAI ◽  
YOSHIO KIYOHARA ◽  
SHUSUKE YOSHIKAWA ◽  
NAO KUSUTANI ◽  
AKIRA ONO ◽  
...  
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Primary Malignant Melanoma

Primary Malignant Melanoma of the Female Urethra: A Case Report with Immunohistochemical Findings

1988 ◽  
Vol 43 (2) ◽  
pp. 110-112 ◽  
Author(s):  
G. Barbagli ◽  
A. Natali ◽  
C. Urso ◽  
G. Barbanti ◽  
I. Menchi ◽  
...  
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Primary Malignant Melanoma ◽  
Female Urethra

Primary Malignant Melanoma of the Urinary Bladder - A Case Report -

2010 ◽  
Vol 44 (2) ◽  
pp. 216
Author(s):  
Sung-Hak Lee ◽  
Eun-Deok Chang ◽  
Eun-Jung Lee ◽  
Chang-Suk Kang
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Urinary Bladder ◽  
Primary Malignant Melanoma

scholarly journals Primary malignant melanoma of the parotid gland: A case report and review of the literature

2020 ◽  
Vol 60 ◽  
pp. 660-663
Author(s):  
Anass Chaouki ◽  
Omar Berrada ◽  
Zouhair Najib ◽  
Youssef oukessou ◽  
Reda Allah Abada ◽  
...  
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Parotid Gland ◽  
Primary Malignant Melanoma ◽  
Review Of The Literature

PS02.182: EFFECTIVENESS OF ANTI-PD-1 ANTIBODY MONOTHERAPY FOR THE PRIMARY MALIGNANT MELANOMA OF THE ESOPHAGUS: A CASE REPORT

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 173-174
Author(s):  
Hiroto Muroi ◽  
Masanobu Nakajima
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Conflicts Of Interest ◽  
Complete Response ◽  
Primary Malignant Melanoma ◽  
Innovative Strategies ◽  
First Case ◽  
Positron Emission ◽  
Programmed Death ◽  
Programmed Death 1

Abstract Background Primary malignant melanoma of the esophagus (PMME) is extraordinarily rare with a high prevalence of malignancy and poor prognosis, and a standard therapy remains to be established. Since conventional therapeutic methods have been limited in their effects on treatment outcomes, innovative strategies for treating PMME are being explored, especially molecular targeting strategies. The programmed death 1 (PD-1) protein/programmed death ligand-1(PD-L1) inhibitor nivolumab is a promising agent for various cancers. To our knowledge, this is the first case report of PMME where a complete response was achieved using nivolumab. Methods We report an 80-year-old woman who was diagnosed with PMME with bone metastasis and lymph node metastases. Although dacarbazine combined chemotherapy was performed and continued for six cycles, the primary tumor deteriorated and liver metastases appeared. The patient then received nivolumab monotherapy (2 mg/kg, once every three weeks). Results After three cycles, nivolumab monotherapy for PMME resulted in a complete response as shown by positron emission tomography, computed tomography, and esophagogastroduodenoscopy. Conclusion In our case, nivolumab exerted a curative effect on PMME, thus suggesting that nivolumab can be effective in the treatment of this rare disease. Disclosure All authors have declared no conflicts of interest.

Flat-type primary malignant melanoma of the esophagus treated by EMR: case report

2005 ◽  
Vol 61 (6) ◽  
pp. 787-789 ◽  
Author(s):  
Hitoshi Kimura ◽  
Hiroyuki Kato ◽  
Makoto Sohda ◽  
Masanobu Nakajima ◽  
Yasuyuki Fukai ◽  
...  
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Primary Malignant Melanoma ◽  
Flat Type

scholarly journals Primary malignant melanoma of the lung: A case report

2017 ◽  
Vol 7 (1) ◽  
pp. 39-41 ◽  
Author(s):  
Yoko Yamamoto ◽  
Ken Kodama ◽  
Tomohiro Maniwa ◽  
Masashi Takeda ◽  
Yuuka Tanaka ◽  
...  
Keyword(s):  
Case Report ◽  
Malignant Melanoma ◽  
Primary Malignant Melanoma
Sign in / Sign up

Export Citation Format

Share Document